The role of the AMPK/ERK1/2 signaling pathway in neuronal oxidative stress damage following cerebral ischemia-reperfusion
Authors:
Open Access
- 10 July 2024
- journal article
- research article
- Published by Elsevier in Tissue and Cell
- Vol. 89, 102472
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- The role of mitochondrial dynamics in cerebral ischemia-reperfusion injuryBiomedicine & Pharmacotherapy, 2023
- Anti-apoptosis effect of traditional Chinese medicine in the treatment of cerebral ischemia–reperfusion injuryApoptosis, 2023
- AMPK: The key to ischemia‐reperfusion injuryJournal of Cellular Physiology, 2022
- Cell Death Mechanisms in Cerebral Ischemia–Reperfusion InjuryNeurochemical Research, 2022
- RETRACTED: AMPK signaling in diabetes mellitus, insulin resistance and diabetic complications: A pre-clinical and clinical investigationBiomedicine & Pharmacotherapy, 2022
- Brain injury after cardiac arrest: pathophysiology, treatment, and prognosisIntensive Care Medicine, 2021
- Deregulated Protein Kinases: Friend and Foe in Ischemic StrokeMolecular Neurobiology, 2021
- Anti-cerebral ischemia reperfusion injury of polysaccharides: A review of the mechanismsBiomedicine & Pharmacotherapy, 2021
- NAD+ precursor modulates post-ischemic mitochondrial fragmentation and reactive oxygen species generation via SIRT3 dependent mechanismsExperimental Neurology, 2020
- Interleukin-11 treatment protected against cerebral ischemia/reperfusion injuryBiomedicine & Pharmacotherapy, 2019